|
Tumor necrosis factor α (TNFα) is a primary mediator of many inflammatory conditions including rheumatoid arthritis, toxic shock, and sepsis.1,2,3 TNFα functions as a trimer and promotes receptor trimerization to activate proinflammatory and/or apoptotic signalling pathways. 4,5 CAY10500 is an inhibitor of TNFα that prevents binding to the TNF Receptor 1 (TNFR1) with an IC50 of 22 µM.6 It binds to the biologically active TNFα trimer and promotes accelerated displacement of a single subunit to rapidly inactivate the cytokine. In a cell based assay, CAY10500 inhibited TNFα-mediated stimulation of IKB degradation with an IC50 of 4.6 µM.6
|
|
1
Beutler, B., Greenwald, D., Hulmes, J.D., et al. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316 552-554 (1985).
2
missing reference text
3
missing reference text
4
Thornberry, N.A., Lazebnik, Y. Caspases: Enemies within. Science 281 1312-1316 (1998).
5
missing reference text
6
He, M.M., Smith, A.S., Oslob, J.D., et al. Small-molecule inhibition of TNF-α Science 310, 1022-1025 (2005).
|